Display screen with graphical user interface for activating drug delivery and communicating drug delivery information

Stonecipher , et al. April 24, 2

Patent Grant D816090

U.S. patent number D816,090 [Application Number D/556,037] was granted by the patent office on 2018-04-24 for display screen with graphical user interface for activating drug delivery and communicating drug delivery information. This patent grant is currently assigned to AMGEN INC.. The grantee listed for this patent is AMGEN INC.. Invention is credited to Michel D. Arney, Maxwell Franklin Bischoff, Laurie Burns, Gregg Allen Flender, Barbara Hartigan, Gail Devan Hunter, Craig Lester, R. Paul Mounce, Gaurav Rohatgi, Bryce George Rutter, Megan Marie Rutter, Kristin Leigh Sjo-Gaber, Brian Stonecipher, Eva Stump.


United States Patent D816,090
Stonecipher ,   et al. April 24, 2018

Display screen with graphical user interface for activating drug delivery and communicating drug delivery information

Claims

CLAIM The ornamental design for a display screen with graphical user interface for activating drug delivery and communicating drug delivery information, as shown and described.
Inventors: Stonecipher; Brian (Newbury Park, CA), Lester; Craig (Westlake Village, CA), Mounce; R. Paul (Burbank, CA), Stump; Eva (Newbury Park, CA), Arney; Michel D. (Wellesley, MA), Bischoff; Maxwell Franklin (Somerville, MA), Burns; Laurie (St. Louis, MO), Flender; Gregg Allen (Bedford, MA), Hartigan; Barbara (Newbury Park, CA), Hunter; Gail Devan (St. Louis, MO), Rohatgi; Gaurav (Waltham, MA), Rutter; Bryce George (Saint Louis, MO), Rutter; Megan Marie (Saint Louis, MO), Sjo-Gaber; Kristin Leigh (West Roxbury, MA)
Applicant:
Name City State Country Type

AMGEN INC.

Thousand Oaks

CA

US
Assignee: AMGEN INC. (Thousand Oaks, CA)
Appl. No.: D/556,037
Filed: February 26, 2016

Current U.S. Class: D14/485
Current International Class: 1404
Field of Search: ;D14/485-495

References Cited [Referenced By]

U.S. Patent Documents
D743972 November 2015 Yoon
D754682 April 2016 Lee
D762716 August 2016 Yang
D763308 August 2016 Wang
D764482 August 2016 Omiya
D765091 August 2016 Del Lima
D765718 September 2016 Vinna
D770517 November 2016 Peng
D775658 January 2017 Luo
D776124 January 2017 Lee
D776126 January 2017 Lai
D777200 January 2017 Luo
D777738 January 2017 Yang
D777744 January 2017 Wang
D779504 February 2017 Cabrera, Jr.
D781299 March 2017 Yun
D782498 March 2017 Krafft
D784402 April 2017 Luo
D785017 April 2017 Wang
D785658 May 2017 Moroney
D786898 May 2017 Hall
D786932 May 2017 Kim
D787551 May 2017 Oh
D788122 May 2017 Tada
D788165 May 2017 Bunyard
D788801 June 2017 Moore
D789956 June 2017 Ortega
D789974 June 2017 Guo
D791806 July 2017 Brewington
D795900 August 2017 Bischoff
D795919 August 2017 Bischoff
D795927 August 2017 Bischoff
9734477 August 2017 Weast
D798311 September 2017 Golden
9750976 September 2017 Weast
D801359 October 2017 Jungmann
D803233 November 2017 Wilberding
D803242 November 2017 Mizono
2011/0193878 August 2011 Seo
2013/0106603 May 2013 Weast
2015/0205511 July 2015 Vinna
2016/0267238 September 2016 Nag
Primary Examiner: Webster; Robin V
Assistant Examiner: Voorhies; Rachel
Attorney, Agent or Firm: Marshall, Gerstein & Borun LLP

Description



A portion of the disclosure of this patent document may contain material to which a claim for copyright is made. The copyright owner has no objection to the reproduction of the patent document or the patent disclosure, as it appears in the U.S. Patent Office records, but reserves all other copyright rights.

The FIGURE is a front view of a display screen with graphical user interface for activating drug delivery and communicating drug delivery information.

The broken line of the display screen and the broken lines showing certain words, numbers, and features in the drawing(s) are for illustrative and environmental purposes only and form no part of the claimed invention.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed